Panacea Life Sciences Holdings, Inc.

PLSH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 13, 2018
4 Sep 13, 2018
4 Sep 13, 2018
8-K Sep 7, 2018 CURRENT PROJECT
8-K Sep 5, 2018 CURRENT REPORT
PRE 14C Aug 31, 2018 PRELIMINARY SCHEDULE 14C
10-Q Aug 20, 2018 QUARTERLY REPORT
NT 10-Q Aug 15, 2018
8-K Jul 20, 2018 CURRENT REPORT
4 Jul 9, 2018
8-K Jul 6, 2018 CURRENT REPORT
10-Q May 21, 2018 QUARTERLY REPORT
NT 10-Q May 15, 2018
10-K Apr 2, 2018 ANNUAL REPORT
4 Mar 30, 2018
4 Mar 30, 2018
4 Mar 30, 2018
4 Mar 30, 2018
8-K Mar 28, 2018 CURRENT REPORT
8-K Mar 28, 2018 CURRENT REPORT
8-K Jan 10, 2018 CURRENT REPORT
8-K Jan 8, 2018
8-K Dec 22, 2017
8-K Nov 24, 2017 FORM 8-K
10-Q Nov 20, 2017 QUARTERLY REPORT
← Newer Page 10 of 13 · 316 filings Older →